Selectis Health, Inc.
GBCS
$1.80
$0.2012.50%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -100.00% | -- | 1.32% | 1.58% |
| Total Other Revenue | 12.37% | 14.97% | 12.71% | 7.46% | -1.23% |
| Total Revenue | 10.48% | 12.99% | 10.73% | 7.35% | -1.18% |
| Cost of Revenue | 7.73% | 1.61% | -1.62% | -0.13% | -11.85% |
| Gross Profit | 20.83% | 73.28% | 81.32% | 44.27% | 81.61% |
| SG&A Expenses | 8.87% | -43.69% | -4.78% | -4.70% | -13.85% |
| Depreciation & Amortization | -14.31% | -15.81% | 4.53% | -6.68% | -3.44% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.07% | -13.94% | -2.36% | -1.55% | -11.98% |
| Operating Income | 39.44% | 96.75% | 51.45% | 51.75% | 64.66% |
| Income Before Tax | 36.60% | 84.13% | 28.96% | 137.81% | -125.71% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 36.60% | 84.13% | 28.96% | 137.81% | -125.71% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 36.60% | 84.13% | 28.96% | 137.81% | -125.71% |
| EBIT | 39.44% | 96.75% | 51.45% | 51.75% | 64.66% |
| EBITDA | 78.47% | 110.36% | 61.20% | 69.03% | 82.20% |
| EPS Basic | 35.61% | 84.23% | 29.16% | 137.16% | -125.83% |
| Normalized Basic EPS | 36.61% | 83.72% | 42.39% | 37.53% | 56.60% |
| EPS Diluted | 35.29% | 83.33% | 29.16% | 137.16% | -125.85% |
| Normalized Diluted EPS | 36.61% | 83.72% | 42.39% | 37.53% | 56.60% |
| Average Basic Shares Outstanding | 0.00% | 0.41% | 0.41% | 0.41% | 0.41% |
| Average Diluted Shares Outstanding | 0.00% | 0.41% | 0.41% | 0.41% | 0.41% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |